Vanda Pharmaceuticals Inc.

Healthcare · Biotechnology · United States

Last price 3.815 USD (Oct 30, 2026, 2:06 PM EDT) · Market cap 230.69M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company’s commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia; HETLIOZ to treat non-24-hour sleep-wake disorders and nighttime sleep disturbances; PONVORY to treat relapsing forms of multiple sclerosis; and NEREUSTM for preventing vomiting induced by motion. It also develop...